Online citations, reference lists, and bibliographies.
← Back to Search

Skin-controlled Release Lipid Nanosystems Of Pranoprofen For The Treatment Of Local Inflammation And Pain.

M. Rincón, A. Calpena, B. Clares, M. Espina, M. L. Garduño-Ramírez, M. J. Rodríguez-Lagunas, M. García, G. Abrego
Published 2018 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
AIM The design and development of pranoprofen (PF) nanostructured lipid carriers (NLCs) for topical treatment of local inflammation and pain. MATERIALS & METHODS PF-NLCs were designed and optimized by central rotatable composite design. A physicochemical characterization was addressed. Release and skin permeation were performed in Franz diffusion cells. In vivo anti-inflammatory efficacy was assayed in mice and tolerance study in humans. RESULTS PF-NLCs F7 and F10 provided sustained release, good stability and optimal skin retention avoiding systemic undesired side effects. Anti-inflammatory activity was enhanced, suggesting an improved efficacy as compared with standard formulation. No skin irritancy was detected. CONCLUSION Topical PF-NLCs F7 and F10 could be effective and safe new therapeutic tools for the treatment of local inflammation and pain. [Formula: see text].
This paper references
10.1016/j.nano.2017.06.021
Amphotericin B releasing topical nanoemulsion for the treatment of candidiasis and aspergillosis.
L. Sosa (2017)
10.1016/J.IJPHARM.2003.10.038
Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge.
A. Kohli (2004)
10.1002/acr.21596
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
M. Hochberg (2012)
10.2165/11631550-000000000-00000
Evolution of Topical NSAIDs in the Guidelines for Treatment of Osteoarthritis in Elderly Patients
P. Arnstein (2012)
10.3390/ijms18122548
Human Skin Permeation Studies with PPARγ Agonist to Improve Its Permeability and Efficacy in Inflammatory Processes
Marcelle Silva-Abreu (2017)
10.1503/cmaj.1031793
Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial
A. Bookman (2004)
10.1016/j.ejps.2013.09.009
Influence of skin penetration enhancers on skin barrier function and skin protease activity.
D. Mohammed (2014)
10.1016/J.JDDST.2015.10.003
From nanoemulsions to nanostructured lipid carriers: A relevant development in dermal delivery of drugs and cosmetics
L. Montenegro (2016)
10.1016/j.colsurfb.2015.03.062
Nanoemulsions for dermal controlled release of oleanolic and ursolic acids: In vitro, ex vivo and in vivo characterization.
H. Alvarado (2015)
10.1016/j.ijpharm.2017.09.026
Glycerosomes: Investigation of role of 1,2-dimyristoyl-sn-glycero-3-phosphatidycholine (DMPC) on the assembling and skin delivery performances.
M. L. Manca (2017)
10.1016/j.jconrel.2013.12.028
Advanced progress of microencapsulation technologies: in vivo and in vitro models for studying oral and transdermal drug deliveries.
P. L. Lam (2014)
10.1016/j.jdermsci.2018.01.010
A lamellar body mimetic system for the treatment of oxazolone-induced atopic dermatitis in hairless mice.
V. Moner (2018)
10.3899/jrheum.090935
Adverse Effects of Topical Nonsteroidal Antiinflammatory Drugs in Older Adults with Osteoarthritis: A Systematic Literature Review
U. Makris (2010)
10.1016/j.nano.2016.12.003
New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9.
E. Sánchez-López (2017)
10.1111/j.1600-0536.1999.tb06147.x
Contact allergy to isopropanolamine in Traxam® gel
S. Cooper (1999)
10.1016/j.semarthrit.2014.05.014
An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
O. Bruyère (2014)
10.1007/s11095-017-2181-8
Developing Transdermal Applications of Ketorolac Tromethamine Entrapped in Stimuli Sensitive Block Copolymer Hydrogels
M. Mallandrich (2017)
10.1016/j.semarthrit.2015.11.011
Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys.
O. Bruyère (2016)
10.1002/jps.24101
Design of nanosuspensions and freeze-dried PLGA nanoparticles as a novel approach for ophthalmic delivery of pranoprofen.
G. Abrego (2014)
10.1016/j.colsurfb.2010.07.029
Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
E. Gonzalez-Mira (2010)
10.1016/j.colsurfb.2015.10.026
Design and elaboration of freeze-dried PLGA nanoparticles for the transcorneal permeation of carprofen: Ocular anti-inflammatory applications.
A. Parra (2015)
10.1016/j.ijpharm.2016.01.056
Ex vivo permeation of carprofen from nanoparticles: A comprehensive study through human, porcine and bovine skin as anti-inflammatory agent.
A. Parra (2016)
10.1016/j.ijpharm.2014.06.009
Fabrication of polyelectrolyte multilayered vesicles as inhalable dry powder for lung administration of rifampicin.
M. L. Manca (2014)
10.1016/J.ADDR.2007.04.012
Nanostructured lipid carriers (NLC) in cosmetic dermal products.
R. Mueller (2007)
10.1016/j.ejpb.2015.01.026
Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration.
G. Abrego (2015)
10.1007/s00403-014-1484-4
Semisolid formulations containing cetirizine: human skin permeation and topical antihistaminic evaluation in a rabbit model
Claudia Ciurlizza (2014)
10.1016/j.colsurfb.2011.03.035
Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound.
A. Silva (2011)
10.1111/ics.12109
Characterization, sensorial evaluation and moisturizing efficacy of nanolipidgel formulations
M. Estanqueiro (2014)
10.1111/pme.12288
Topical NSAID formulations.
M. McPherson (2013)
10.1002/ART.20247
Informed choice and the widespread use of antiinflammatory drugs.
L. Fraenkel (2004)
10.3109/02652048.2010.513456
Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies
D. Liu (2010)
10.1208/s12249-016-0529-8
Development of Clotrimazole Multiple W/O/W Emulsions as Vehicles for Drug Delivery: Effects of Additives on Emulsion Stability
Joaquim Suñer (2016)
10.1016/j.joca.2007.12.013
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.
W. Zhang (2008)
10.1016/j.colsurfb.2013.12.009
Development and characterization of two nano-structured systems for topical application of flavanones isolated from Eysenhardtia platycarpa.
Valeri Domínguez-Villegas (2014)
10.1016/j.ijpharm.2013.07.060
Glycerosomes: a new tool for effective dermal and transdermal drug delivery.
M. L. Manca (2013)
10.1016/j.nano.2015.09.004
Nanostructured lipid carriers: Promising drug delivery systems for future clinics.
A. Beloqui (2016)
10.1016/j.ejpb.2016.08.001
Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation.
S. Doktorovová (2016)
10.1016/j.nano.2015.01.004
Design and optimization of oleanolic/ursolic acid-loaded nanoplatforms for ocular anti-inflammatory applications.
H. Alvarado (2015)
10.1016/j.ejps.2012.08.016
Comparison of the efficacy and skin permeability of topical NSAID preparations used in Europe.
T. Komatsu (2012)
10.1021/LA9904758
Forces between Emulsion Droplets Stabilized with Tween 20 and Proteins
and Tatiana D. Dimitrova (1999)
10.1016/j.ijpharm.2016.01.071
Biopharmaceutical profile of hydrogels containing pranoprofen-loaded PLGA nanoparticles for skin administration: In vitro, ex vivo and in vivo characterization.
G. Abrego (2016)
10.4062/BIOMOLTHER.2008.16.3.210
Enhanced Bioavailability by Transdermal Administration of Pranoprofen Gels Containing Octanoic Acid to Rats
J. Choi (2008)
10.1016/J.IJPHARM.2005.10.044
On the use of the Weibull function for the discernment of drug release mechanisms.
V. Papadopoulou (2006)
10.1016/j.ijpharm.2014.10.031
Development of novel diolein-niosomes for cutaneous delivery of tretinoin: influence of formulation and in vitro assessment.
M. L. Manca (2014)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar